HEPATITIS C - THE WIDER CONTEXT

Abstract

Get full access to this article

View all access options for this article.

References

1National Institute of Clinical Excellence. Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C: Technology appraisal 75. London: NICE; 2004.

2 Booth

JCL

O'Grady

Neuberger

Clinical guidelines on the management of hepatitis C. Gut 2001; 49(suppl 1):i1-i21.

3NIH Consensus panel. NIH consensus development conference statement: management of hepatitis C. Gastroenterology 2002; 123:2082-9.

Seeff

LB.

Natural history of chronic hepatitis C. Hepatology 2002; 36:535-546.